Aratana Therapeutics, Inc. EBITDA Margin 2013-2019 | PETX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Aratana Therapeutics, Inc. (PETX) over the last 10 years. The current EBITDA margin for Aratana Therapeutics, Inc. as of March 31, 2019 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2019-03-31 | $0.04B | $-0.01B | -23.08% |
| 2018-12-31 | $0.04B | $-0.01B | -27.78% |
| 2018-09-30 | $0.04B | $-0.02B | -43.90% |
| 2018-06-30 | $0.03B | $-0.04B | -144.00% |
| 2018-03-31 | $0.03B | $-0.04B | -160.00% |
| 2017-12-31 | $0.03B | $-0.04B | -172.00% |
| 2017-09-30 | $0.02B | $-0.05B | -340.00% |
| 2017-06-30 | $0.01B | $-0.06B | -611.11% |
| 2017-03-31 | $0.04B | $-0.02B | -57.14% |
| 2016-12-31 | $0.04B | $-0.03B | -78.95% |
| 2016-09-30 | $0.04B | $-0.02B | -50.00% |
| 2016-06-30 | $0.04B | $-0.06B | -160.53% |
| 2016-03-31 | $0.00B | $-0.09B | inf% |
| 2015-12-31 | $0.00B | $-0.09B | inf% |
| 2015-09-30 | $0.00B | $-0.09B | inf% |
| 2015-06-30 | $0.00B | $-0.04B | inf% |
| 2015-03-31 | $0.00B | $-0.04B | inf% |
| 2014-12-31 | $0.00B | $-0.04B | inf% |
